Celsius (NASDAQ:CELH – Get Free Report) had its price target cut by UBS Group from $73.00 to $65.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target suggests a potential upside of 54.83% from the company’s current price.
Other equities analysts have also issued research reports about the stock. Cowen reissued a “buy” rating on shares of Celsius in a report on Tuesday, September 2nd. Zacks Research lowered Celsius from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Roth Capital reiterated a “buy” rating on shares of Celsius in a report on Thursday, October 2nd. Citigroup reissued a “buy” rating on shares of Celsius in a report on Sunday, August 31st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Celsius in a research report on Wednesday. Twenty analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $63.10.
Get Our Latest Analysis on Celsius
Celsius Stock Down 6.8%
Celsius (NASDAQ:CELH – Get Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.28 by $0.14. The business had revenue of $725.11 million for the quarter, compared to analyst estimates of $703.68 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business’s quarterly revenue was up 172.9% on a year-over-year basis. Equities analysts predict that Celsius will post 0.89 EPS for the current year.
Insider Transactions at Celsius
In related news, insider Paul H. Storey sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total value of $456,975.00. Following the sale, the insider owned 37,550 shares in the company, valued at approximately $2,287,921.50. This trade represents a 16.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jarrod Langhans sold 5,000 shares of the business’s stock in a transaction dated Thursday, October 16th. The shares were sold at an average price of $65.00, for a total value of $325,000.00. Following the sale, the chief financial officer owned 99,227 shares of the company’s stock, valued at approximately $6,449,755. This represents a 4.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 57,500 shares of company stock valued at $3,581,975. Insiders own 2.55% of the company’s stock.
Institutional Trading of Celsius
Institutional investors and hedge funds have recently modified their holdings of the company. Alliancebernstein L.P. raised its holdings in Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after acquiring an additional 3,753,055 shares during the period. Scopus Asset Management L.P. purchased a new stake in shares of Celsius during the 2nd quarter worth approximately $59,382,000. Ilex Capital Partners UK LLP bought a new position in Celsius during the second quarter valued at $55,966,000. Holocene Advisors LP lifted its holdings in shares of Celsius by 130.6% in the 2nd quarter. Holocene Advisors LP now owns 2,108,041 shares of the company’s stock valued at $97,792,000 after acquiring an additional 1,193,707 shares during the last quarter. Finally, AQR Capital Management LLC purchased a new position in shares of Celsius in the 1st quarter worth approximately $39,412,000. 60.95% of the stock is currently owned by institutional investors.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- How to Start Investing in Real Estate
- Cameco Stock Falls After Earnings, Why the Dip May Be a Gift
- Stock Splits, Do They Really Impact Investors?
- Amgen Stock: New All-Time Highs Ahead After Earnings Beat
- Stock Dividend Cuts Happen Are You Ready?
- Netflix Stock Split Explained: What It Means for Investors
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.
